The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients

BACKGROUND: Despite its efficacy, FAC regimen may cause fatal cardiotoxicity. Carvedilol may also exert additional antioxidant effects. This study aimed to assess the effect of carvedilol in preventing decline of left ventricular function in breast cancer patients receiving FAC regimen chemotherapy....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Cardiol Heart Vasc
Asıl Yazarlar: Wibawa Martha, Januar, Soedarsono, Dery A., Iqbal, Mohammad, Astuti, Astri, Martanto, Erwan, Rizki Akbar, Mohammad, Sumantra, I. Gede
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2020
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7339049/
https://ncbi.nlm.nih.gov/pubmed/32671185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100575
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller